Report Overview
Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Platinum Based Cancer Drug market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Platinum Based Cancer Drug market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Platinum Based Cancer Drug market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Platinum Based Cancer Drug products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Platinum Based Cancer Drug products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Platinum Based Cancer Drug market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Platinum Based Cancer Drug development has been the leading industry trend of Platinum Based Cancer Drug market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Platinum Based Cancer Drug Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Cisplatin,Oxaliplatin,Carboplatin,Other |
| By Application Outlook |
Colorectal Cancer,Ovarian Cancer,Lung Cancer,Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Sanofi,Hengrui Medicine,ASK Pharma,Yi Bai Pharmaceutical,Qilu Pharmaceutical,Teva,Pfizer,Dr Reddy's Laboratories,Mylan,Sun Pharma,Novartis,Debiopharm,Accord Healthcare,SK Chemicals |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Sanofi
- Hengrui Medicine
- ASK Pharma
- Yi Bai Pharmaceutical
- Qilu Pharmaceutical
- Teva
- Pfizer
- Dr Reddy's Laboratories
- Mylan
- Sun Pharma
- Novartis
- Debiopharm
- Accord Healthcare
- SK Chemicals
Platinum Based Cancer Drug Market, By Type
- Cisplatin
- Oxaliplatin
- Carboplatin
- Other
Platinum Based Cancer Drug Market, By Application
- Colorectal Cancer
- Ovarian Cancer
- Lung Cancer
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table Of Contents
Table of Contents
Global Platinum Based Cancer Drug Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Platinum Based Cancer Drug Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Platinum Based Cancer Drug Industry Overview
2.1 Global Platinum Based Cancer Drug Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Platinum Based Cancer Drug Global Import Market Analysis
2.1.2 Platinum Based Cancer Drug Global Export Market Analysis
2.1.3 Platinum Based Cancer Drug Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Cisplatin
2.2.2 Oxaliplatin
2.2.3 Carboplatin
2.2.4 Other
2.3.2 Ovarian Cancer
2.3.3 Lung Cancer
2.3.4 Other
2.4.2 Global Platinum Based Cancer Drug Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Platinum Based Cancer Drug Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Platinum Based Cancer Drug Manufacturer Market Share
2.4.5 Top 10 Platinum Based Cancer Drug Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Platinum Based Cancer Drug Market
2.4.7 Key Manufacturers Platinum Based Cancer Drug Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Platinum Based Cancer Drug Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Platinum Based Cancer Drug Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Platinum Based Cancer Drug Market Size Categorized by Regions
4.1 Global Platinum Based Cancer Drug Revenue, Sales and Market Share by Regions
4.1.1 Global Platinum Based Cancer Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Platinum Based Cancer Drug Revenue and Market Share by Regions (2015-2020)
4.2 Europe Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
4.3 APAC Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
4.4 North America Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
4.5 South America Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
5 Europe Platinum Based Cancer Drug Market Size Categorized by Countries
5.1 Europe Platinum Based Cancer Drug Sales, Revenue and Market Share by Countries
5.1.1 Europe Platinum Based Cancer Drug Sales by Countries (2015-2020)
5.1.2 Europe Platinum Based Cancer Drug Revenue by Countries (2015-2020)
5.1.3 Germany Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
5.1.4 UK Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
5.1.5 France Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
5.1.6 Russia Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
5.1.7 Italy Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
5.1.8 Spain Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
5.2 Europe Platinum Based Cancer Drug Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Platinum Based Cancer Drug Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Platinum Based Cancer Drug Sales Market Share by Type (2015-2020)
5.3.2 Europe Platinum Based Cancer Drug Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Platinum Based Cancer Drug Sales Market Share by Application (2015-2020)
6 Asia-Pacific Platinum Based Cancer Drug Market Size Categorized by Countries
6.1 Asia-Pacific Platinum Based Cancer Drug Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Platinum Based Cancer Drug Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Platinum Based Cancer Drug Revenue by Countries (2015-2020)
6.1.3 China Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
6.1.4 Japan Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
6.1.5 Korea Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
6.1.6 India Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
6.1.8 Australia Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Platinum Based Cancer Drug Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Platinum Based Cancer Drug Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Platinum Based Cancer Drug Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Platinum Based Cancer Drug Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Platinum Based Cancer Drug Sales and Market Share by Application (2015-2020)
7 North America Platinum Based Cancer Drug Market Size Categorized by Countries
7.1 North America Platinum Based Cancer Drug Sales, Revenue and Market Share by Countries
7.1.1 North America Platinum Based Cancer Drug Sales by Countries (2015-2020)
7.1.2 North America Platinum Based Cancer Drug Revenue by Countries (2015-2020)
7.1.3 United States Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
7.1.4 Canada Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
7.1.5 Mexico Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
7.2 North America Platinum Based Cancer Drug Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Platinum Based Cancer Drug Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Platinum Based Cancer Drug Sales Market Share by Type (2015-2020)
7.3.2 North America Platinum Based Cancer Drug Revenue and Revenue Share by Type (2015-2020)
7.4 North America Platinum Based Cancer Drug Sales Market Share by Application (2015-2020)
8 South America Platinum Based Cancer Drug Market Size Categorized by Countries
8.1 South America Platinum Based Cancer Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Platinum Based Cancer Drug Sales by Countries (2015-2020)
8.1.2 South America Platinum Based Cancer Drug Revenue by Countries (2015-2020)
8.1.3 Brazil Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
8.2 South America Platinum Based Cancer Drug Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Platinum Based Cancer Drug Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Platinum Based Cancer Drug Sales Market Share by Type (2015-2020)
8.3.2 South America Platinum Based Cancer Drug Revenue and Revenue Share by Type (2015-2020)
8.4 South America Platinum Based Cancer Drug Sales Market Share by Application (2015-2020)
9 Middle East and Africa Platinum Based Cancer Drug Market Size Categorized by Countries
9.1 Middle East and Africa Platinum Based Cancer Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Platinum Based Cancer Drug Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Platinum Based Cancer Drug Revenue by Countries (2015-2020)
9.1.3 GCC Countries Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
9.1.4 Turkey Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
9.1.5 Egypt Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
9.1.6 South Africa Platinum Based Cancer Drug Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Platinum Based Cancer Drug Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Platinum Based Cancer Drug Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Platinum Based Cancer Drug Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Platinum Based Cancer Drug Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Platinum Based Cancer Drug Sales Market Share by Application (2015-2020)
10 Global Platinum Based Cancer Drug Market Segment by Type
10.1 Global Platinum Based Cancer Drug Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Platinum Based Cancer Drug Sales and Market Share by Type (2015-2020)
10.1.2 Global Platinum Based Cancer Drug Revenue and Market Share by Type (2015-2020)
10.2 Cisplatin Sales Growth Rate and Price
10.2.1 Global Cisplatin Sales Growth Rate (2015-2020)
10.2.2 Global Cisplatin Price (2015-2020)
10.3 Oxaliplatin Sales Growth Rate and Price
10.3.1 Global Oxaliplatin Sales Growth Rate (2015-2020)
10.3.2 Global Oxaliplatin Price (2015-2020)
10.4 Carboplatin Sales Growth Rate and Price
10.4.1 Global Carboplatin Sales Growth Rate (2015-2020)
10.4.2 Global Carboplatin Price (2015-2020)
10.5 Other Sales Growth Rate and Price
10.5.1 Global Other Sales Growth Rate (2015-2020)
10.5.2 Global Other Price (2015-2020)
11.1 Global Platinum Based Cancer DrugSales Market Share by Application (2015-2020)
11.2 Colorectal Cancer Sales Growth Rate (2015-2020)
11.3 Ovarian Cancer Sales Growth Rate (2015-2020)
11.4 Lung Cancer Sales Growth Rate (2015-2020)
11.5 Other Sales Growth Rate (2015-2020)
12.1 Global Platinum Based Cancer Drug Revenue, Sales and Growth Rate (2020-2027)
12.2 Platinum Based Cancer Drug Market Forecast by Regions (2020-2027)
12.2.1 Europe Platinum Based Cancer Drug Market Forecast (2020-2027)
12.2.2 APAC Platinum Based Cancer Drug Market Forecast (2020-2027)
12.2.3 North America Platinum Based Cancer Drug Market Forecast (2020-2027)
12.2.4 South America Platinum Based Cancer Drug Market Forecast (2020-2027)
12.2.5 Middle East & Africa Platinum Based Cancer Drug Market Forecast (2020-2027)
12.3 Platinum Based Cancer Drug Market Forecast by Type (2020-2027)
12.3.1 Global Platinum Based Cancer Drug Sales Forecast by Type (2020-2027)
12.3.2 Global Platinum Based Cancer Drug Market Share Forecast by Type (2020-2027)
12.4 Platinum Based Cancer Drug Market Forecast by Application (2020-2027)
12.4.1 Global Platinum Based Cancer Drug Sales Forecast by Application (2020-2027)
12.4.2 Global Platinum Based Cancer Drug Market Share Forecast by Application (2020-2027)
13 Analysis of Platinum Based Cancer Drug Industry Key Manufacturers
13.1 Sanofi
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Sanofi Platinum Based Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Sanofi News
13.2 Hengrui Medicine
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Hengrui Medicine Platinum Based Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Hengrui Medicine News
13.3 ASK Pharma
13.3.1 Company Details
13.3.2 Product Information
13.3.3 ASK Pharma Platinum Based Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 ASK Pharma News
13.4 Yi Bai Pharmaceutical
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Yi Bai Pharmaceutical Platinum Based Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Yi Bai Pharmaceutical News
13.5 Qilu Pharmaceutical
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Qilu Pharmaceutical Platinum Based Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Qilu Pharmaceutical News
13.6 Teva
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Teva Platinum Based Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Teva News
13.7 Pfizer
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Pfizer Platinum Based Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Pfizer News
13.8 Dr Reddy's Laboratories
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Dr Reddy's Laboratories Platinum Based Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Dr Reddy's Laboratories News
13.9 Mylan
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Mylan Platinum Based Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Mylan News
13.10 Sun Pharma
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Sun Pharma Platinum Based Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Sun Pharma News
13.11 Novartis
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Novartis Platinum Based Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Novartis News
13.12 Debiopharm
13.12.1 Company Details
13.12.2 Product Information
13.12.3 Debiopharm Platinum Based Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.12.4 Main Business Overview
13.12.5 Debiopharm News
13.13 Accord Healthcare
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Accord Healthcare Platinum Based Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.13.4 Main Business Overview
13.13.5 Accord Healthcare News
13.14 SK Chemicals
13.14.1 Company Details
13.14.2 Product Information
13.14.3 SK Chemicals Platinum Based Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.14.4 Main Business Overview
13.14.5 SK Chemicals News
15 Appendix